PDT Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Sell |
43,512
-11,589
| -21% | -$865K | 0.18% | 193 |
|
|
2025
Q1 | $3.5M | Buy |
55,101
+44,933
| +442% | +$2.86M | 0.25% | 129 |
|
|
2024
Q4 | $794K | Buy |
+10,168
| New | +$794K | 0.07% | 385 |
|
|
2022
Q3 | – | Sell |
-5,703
| Closed | -$372K | – | 934 |
|
|
2022
Q2 | $372K | Sell |
5,703
-17,850
| -76% | -$1.16M | 0.03% | 687 |
|
|
2022
Q1 | $1.49M | Buy |
+23,553
| New | +$1.49M | 0.13% | 245 |
|
|
2020
Q3 | – | Sell |
-6,909
| Closed | -$619K | – | 780 |
|
|
2020
Q2 | $619K | Buy |
+6,909
| New | +$619K | 0.04% | 359 |
|
|
2013
Q4 | – | Sell |
-8,300
| Closed | -$331K | – | 841 |
|
|
2013
Q3 | $331K | Sell |
8,300
-16,853
| -67% | -$672K | 0.01% | 1210 |
|
|
2013
Q2 | $1.04M | Buy |
+25,153
| New | +$1.04M | 0.03% | 800 |
|